🇺🇸 FDA
Patent

US 6127426

10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals

expired A61KA61K31/122A61K8/35

Quick answer

US patent 6127426 (10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Oct 03 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/122, A61K8/35, A61P, A61P17/00